HomeITOS • NASDAQ
add
iTeos Therapeutics Inc
Previous close
$17.96
Day range
$17.50 - $18.43
Year range
$8.20 - $18.75
Market cap
643.78M USD
Avg Volume
474.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 46.43M | 24.87% |
Net income | -38.22M | -145.75% |
Net profit margin | — | — |
Earnings per share | -1.07 | -143.18% |
EBITDA | -46.13M | -89.31% |
Effective tax rate | -6.15% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 449.14M | -25.41% |
Total assets | 629.77M | -13.53% |
Total liabilities | 88.57M | 16.41% |
Total equity | 541.20M | — |
Shares outstanding | 36.12M | — |
Price to book | 1.19 | — |
Return on assets | -17.89% | — |
Return on capital | -20.57% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -38.22M | -145.75% |
Cash from operations | -32.40M | -22.01% |
Cash from investing | -69.60M | -119.60% |
Cash from financing | 22.00K | -96.19% |
Net change in cash | -104.53M | -75.86% |
Free cash flow | -39.37M | -69.30% |
About
Founded
2011
Headquarters
Website
Employees
157